American Journal of Roentgenology, Vol 168, 719-723, Copyright © 1997 by American Roentgen Ray Society

ARTICLES

Benign and malignant portal vein thrombosis: differentiation by CT characteristics

ME Tublin, GD Dodd 3rd and RL Baron
Department of Radiology, University of Pittsburgh Medical Center, PA 15213, USA.

OBJECTIVE: The purpose of this study was to determine if unique characteristics revealed by CT can allow radiologists to reliably distinguish benign from malignant portal vein thrombus (PVT) in patients with cirrhosis. MATERIALS AND METHODS: CT examinations of 58 patients with cirrhosis and PVT were retrospectively reviewed. Images were assessed for location, extent, enhancement, neovascularity, and maximal diameter of PVT. The type of PVT was proven histologically in 42 patients and clinically in the remaining 16 patients. Using different threshold PVT diameters or the presence of PVT neovascularity, we calculated the sensitivity and specificity of CT for revealing malignant PVT. RESULTS: Forty-seven patients had malignant and 11 patients had benign PVT. CT scans of patients with malignant PVT showed direct extension of hepatocellular carcinoma into the portal vein in 15 patients. In 29 patients with malignant PVT, CT scans showed PVT adjacent to tumor; CT scans showed tumor PVT remote from hepatocellular carcinoma in the remaining three patients with malignant PVT. The mean diameters of malignant and benign portal vein thrombi were significantly different (23.4 mm versus 16 mm; p = .0001). CT scans of 83% (39/47) of patients with malignant PVT and 18% (2/11) of patients with benign PVT showed generalized enhancement. Neovascularity was seen on CT scans in 43% (20/47) of patients with malignant PVT and in no patient with benign PVT. Identification of a main PVT diameter greater than or equal to 23 mm or PVT neovascularity resulted in a sensitivity and specificity for the CT characterization of malignant PVT of 86% and 100%, respectively. CONCLUSION: Malignant and benign thrombi can often be differentiated by radiologists on the basis of CT imaging characteristics.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. M. Willatt, H. K. Hussain, S. Adusumilli, and J. A. Marrero MR Imaging of Hepatocellular Carcinoma in the Cirrhotic Liver: Challenges and Controversies Radiology, May 1, 2008; 247(2): 311 - 330. [Abstract] [Full Text] [PDF]

				Z. K. Shah, M. G. McKernan, P. F. Hahn, and D. V. Sahani Enhancing and Expansile Portal Vein Thrombosis: Value in the Diagnosis of Hepatocellular Carcinoma in Patients with Multiple Hepatic Lesions Am. J. Roentgenol., May 1, 2007; 188(5): 1320 - 1323. [Abstract] [Full Text] [PDF]

				S. Rossi, L. Rosa, V. Ravetta, A. Cascina, P. Quaretti, A. Azzaretti, P. Scagnelli, C. Tinelli, P. Dionigi, and F. Calliada Contrast-enhanced versus conventional and color Doppler sonography for the detection of thrombosis of the portal and hepatic venous systems. Am. J. Roentgenol., March 1, 2006; 186(3): 763 - 773. [Abstract] [Full Text] [PDF]

				K. D. Evans and J. Schneider Tumor Masquerading as a Portal Vein Thrombosis Journal of Diagnostic Medical Sonography, June 1, 2004; 20(3): 188 - 193. [Abstract] [PDF]

				J.-S. Yu and N. M. Rofsky Dynamic Subtraction MR Imaging of the Liver: Advantages and Pitfalls Am. J. Roentgenol., May 1, 2003; 180(5): 1351 - 1357. [Full Text] [PDF]

				M. E. Baker, F. Remzi, D. Einstein, M. Oncel, B. Herts, E. Remer, and V. Fazio CT Depiction of Portal Vein Thrombi after Creation of Ileal Pouch-Anal Anastomosis Radiology, April 1, 2003; 227(1): 73 - 79. [Abstract] [Full Text] [PDF]

				J. Szklaruk, P. M. Silverman, and C. Charnsangavej Imaging in the Diagnosis, Staging, Treatment, and Surveillance of Hepatocellular Carcinoma Am. J. Roentgenol., February 1, 2003; 180(2): 441 - 454. [Full Text] [PDF]